Cosmetic Labeling Requirements: What Must Appear on Pack

Key Takeaways

• Most markets expect clear identity, net quantity, ingredient information, and a responsible contact path—exact formats differ by country.
• Ingredient order and naming usually follow descending concentration rules and INCI-style names; check the destination rule set.
• Claims on the label can change whether a product is treated as a cosmetic or something else (for example, a drug in the U.S.).
• Artwork approval is not the same as destination-market registration.
• Use a checklist before you lock print plates or digital print files.

What do labeling rules usually try to answer?

Conclusion first: a cosmetic label should answer four buyer questions—what is this, how much is in the pack, what is in it, and who stands behind it.

U.S. cosmetics labeling themes are summarized on the FDA cosmetics labeling pages. Read those pages for the current agency framing; this article restates the educational structure brands use when planning artwork, not a substitute for counsel.

If you are also tracking U.S. facility and listing duties under MoCRA, see MoCRA compliance. Label text and MoCRA listing are related compliance tracks, not identical tasks.

Which information blocks appear on most cosmetic packs?

INCI (everyday gloss): the International Nomenclature of Cosmetic Ingredients naming system used on many markets’ ingredient lists.

PAO (everyday gloss): “period after opening”—a symbol and month count used in some markets to show how long a product may be used after first opening.

Prink factory note (deliverables, not a legal opinion): confirmed export document support when batch records exist includes INCI, COA, SDS/MSDS, packing list, commercial invoice, and technical documents. Filling and labeling are listed among customization and production services (fragrance, color, texture, actives, packaging, filling and labeling). Destination-market registration and customer trademarks are explicitly outside default service scope—so label artwork coordination is not the same as registering the product in the buyer’s country.

Deciding between “fragrance free” and “unscented” for the front of your pack? Our guide to fragrance free vs unscented explains what each claim means and what the FDA and AAD say about them.

For help interpreting the names and order of ingredients separately from other package information, read our guide to an inci list.

How do U.S. cosmetic labels differ from “drug” style claims?

Conclusion first: in the U.S., intended use and claims help decide whether FDA treats a product as a cosmetic, a drug, or both.

Cosmetics are generally for cleansing, beautifying, or altering appearance. Disease treatment or prevention language can push a product into drug territory. Keep claim language aligned with the product’s regulatory path before you print. Start from the FDA cosmetics hub and the labeling pages linked above.

"Products intended to affect the structure or function of the body, or for a therapeutic purpose, such as treating or preventing disease, are subject to regulation as drugs."

Source: U.S. FDA, Cosmetics Labeling

MoCRA adds facility registration, product listing, and related duties for covered cosmetics. It does not replace reading the labeling rules for what must appear on the pack itself.

When do multi-market brands need a different label strategy?

Plan market-specific artwork when:

• Ingredient declaration rules differ (allergens, order, language)
• Net content unit rules differ
• Warning statements are mandatory for the category
• Arabic, EU, ASEAN, or other local language blocks are required

Do not assume one English U.S. panel covers:

• EU Cosmetic Product Regulation labeling formats
• ASEAN notification labeling expectations
• Markets that require local responsible-person wording

This guide does not invent a nine-market comparison table of statutes. Use qualified local reviewers when you ship outside your home market.

How should brands sequence artwork, filling, and documents?

A practical sequence many teams follow:

1. Lock formula version and INCI draft from the approved composition.
2. Lock claims that match the regulatory path.
3. Design primary and secondary panels with required blocks.
4. Approve print proofs against the ingredient and claims file.
5. Run filling and labeling against the approved artwork version.
6. Keep lot coding and document packs aligned to that version.

Prink factory note (process capability): private-label and finished-goods paths describe coordinated labeling, packaging, filling, and packing with artwork approval and production records when the project includes those steps. Quality pages describe document packs for export buyers when records exist. Standard bulk / private-label planning uses a 50 kg MOQ and about 7–15 days ship planning after approval—planning intervals, not guaranteed calendars. Full custom OEM timelines are separate.

For how formula approval precedes pack work, see cosmetic formulation and how it works.

Quick checklist: are you ready to print?

• Product identity wording matches the marketed product
• Net quantity format matches the destination rule set
• Ingredient list matches the approved formula version (INCI)
• Responsible-person / distributor block is complete for the market
• Claims were reviewed for cosmetic vs drug risk (U.S.) or local equivalents
• Warnings / directions included when required
• Lot / PAO / expiry approach matches stability and market practice
• Artwork version ID matches filling work order
• Document pack list (INCI / COA / SDS) requested for intake if needed
• Destination registration is owned by the brand (not assumed done by the factory)

FAQ

Sources

1. FDA Cosmetics Labeling
2. FDA Cosmetics
3. Modernization of Cosmetics Regulation Act of 2022 (MoCRA)